GEODE CAPITAL MANAGEMENT, LLC
Position in RNAC — Cartesian Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in RNAC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,714,989
+$2,093,271 QoQ
Shares Held
356,525
+35.2% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 95 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. RNAC ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RNAC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,714,989 | 356,525 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,621,718 | 263,694 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,842,435 | 255,539 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,471,492 | 241,829 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,274,651 | 218,927 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,972,089 | 225,500 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,962,712 | 221,257 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,187,483 | 135,700 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,591,329 | 132,963 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,624,316 | 2,498,949 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,679,892 | 2,438,160 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,527,860 | 2,384,774 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,651,351 | 2,367,278 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,687,220 | 1,213,828 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,327,493 | 1,174,773 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,988,347 | 1,212,407 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,493,634 | 1,140,179 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,134,737 | 1,735,559 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,711,125 | 1,751,879 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,202,128 | 1,731,281 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,780,996 | 1,622,248 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,329,312 | 1,398,743 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,615,343 | 1,193,183 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,736,841 | 1,103,565 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,042,241 | 719,099 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $688,496 | 285,683 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||